NCT06597539View on ClinicalTrials.gov

The Value of 68Ga-grazytracer PET in Monitoring Responses to Immunotherapy of Advanced Hepatobiliary Malignancy

RecruitingOBSERVATIONAL

Enrollment

40

Participants

Timeline

Start Date

November 9, 2024

Primary Completion Date

June 30, 2026

Study Completion Date

July 31, 2027

Conditions

Hepatobiliary Malignancy

Trial Locations (1)

200025

RECRUITING

Ruijin Hospital affiliated to Shanghai Jiao Tong University of Medicine, Shanghai

All Listed Sponsors

lead

Ruijin Hospital

OTHER